+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compounds active in correcting sulfonamide-induced granulocytopenia in rats



Compounds active in correcting sulfonamide-induced granulocytopenia in rats



Archives of Biochemistry 9: 451-454




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052269397

Download citation: RISBibTeXText

PMID: 21023619


Related references

Compounds active in correcting sulfonamide induced grannlocytopenia in rats. Arch. Biochem, 9: 451-454, 1946

Studies on the transport mechanism of sulfonamide compounds in renal tubules. Stopflow analysis applied to the excretion of sulfonamide compounds. Japanese Circulation Journal 31(3): 423-433, 1967

Blood changes related to sulfonamide therapy; granulocytopenia associated with use of sulfonamides. American Journal of the Medical Sciences 211: 666-671, 2018

Blood changes related to sulfonamide therapy. II. Granulocytopenia associated with the use of sulfonamides. Amer Jour Med Sci 211(6): 666-671, 1946

Neutrophil associated antibodies and granulocytopenia in the sulfonamide reaction in acquired immune deficiency syndrome. Clinical Research 33(2 Part 1): 413A, 1985

Blood changes related to sulfonamide therapy. 3. Treatment of granulocytopenia with folic acid and pyridoxine hydrochloride. Amer. J. Med. Sci, 211: 672-679, 1946

Blood changes related to sulfonamide therapy; treatment of granulocytopenia with folic acid and pyridoxine hydrochloride. American Journal of the Medical Sciences 211: 672-679, 2011

Blood changes related to sulfonamide therapy. III. Treatment of granulocytopenia with folic acid and pyridoxine hydrochloride. Amer Jour Med Sci 211(6): 672-679, 1946

Granulocyte colony-stimulating factor treatment (G-CSF) of antithyroid drug-induced granulocytopenia: granulocyte count measurement after 4 hours of G-CSF injection is useful for the detection of recovery from granulocytopenia. Nihon Naibunpi Gakkai Zasshi 70(5): 517-520, 1994

Use of thin-layer chromatography for identification of active components of drug compounds. II. Drugs containing barbituric acid or sulfonamide derivatives. Acta Poloniae Pharmaceutica 39(1-3): 135-141, 1982

Experimental studies on sensitization of guinea pigs with sulfonamide and sulfonamide compounds. II. Arztliche Forschung 7(3): Ii/45-8; Contd, 1953

Synthesis of organometallic-based biologically active compounds: In vitro antibacterial, antifungal and cytotoxic properties of some sulfonamide incorporated ferrocences. Journal of Enzyme Inhibition and Medicinal Chemistry 24(1): 169-175, 2008

Autochthonous, acetoxymethylmethylnitrosamine-induced colorectal cancer in rats: a useful tool in selecting new active antineoplastic compounds?. Hepato-Gastroenterology 33(5): 227-234, 1986

Vemurafenib-induced toxic epidermal necrolysis: possible cross-reactivity with other sulfonamide compounds. British Journal of Dermatology 174(3): 621-624, 2017

Sulfonamide induced arthritis in rats. Clinical Research 30(1): 55A, 1982